Zobrazeno 1 - 2
of 2
pro vyhledávání: '"59"'
Autor:
Ryan A. Langlois, Brian E. Driver, Nicholas E. Ingraham, David A. Wacker, Michelle H. Biros, Christopher J. Tignanelli, Joseph S. Koopmeiners, Helen Voelker, M. Fernanda Bellolio, Michael A. Puskarich, Thomas A. Murray, Tyler D. Bold, Timothy W. Schacker, Nathan W. Cummins, Jeffrey G. Chipman, Kenneth B. Beckman, Ronald Reilkoff, Matthew T. Aliota, Andrew C. Nelson
Publikováno v:
EClinicalMedicine, Vol 37, Iss, Pp 100957-(2021)
EClinicalMedicine
EClinicalMedicine
Background The SARS-CoV-2 virus enters cells via Angiotensin-converting enzyme 2 (ACE2), disrupting the renin-angiotensin-aldosterone axis, potentially contributing to lung injury. Treatment with angiotensin receptor blockers (ARBs), such as losartan
Autor:
Luis Alvarez, German Astudillo, Adrian Luis Lifschitz, Florencia Facelli Fernández, Marcelo A. Tinelli, Georgina Alexandra Cardama, Javier Farina, Silvia Gold, Alejandro J. Krolewiecki, Carlos Edmundo Lanusse, Marcelo D. Golemba, Diego Fernández de Oliveira, Rubén O. Cimino, Ricardo Valentini, Marina Travacio, Laura Ceballos, Daniel F. Alonso, Inés Baeck, Matías Moragas, Pedro Emanuel Fleitas, Andrea Mangano, Rubén Solari, Eduardo Spitzer
Publikováno v:
EClinicalMedicine
EClinicalMedicine, Vol 37, Iss, Pp 100959-(2021)
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
EClinicalMedicine, Vol 37, Iss, Pp 100959-(2021)
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
Background: There are limited antiviral options for the treatment of patients with COVID-19. Ivermectin (IVM), a macrocyclic lactone with a wide anti-parasitary spectrum, has shown potent activity against SARSCoV-2 in vitro. This study aimed at asses